Format

Send to

Choose Destination
J Cardiovasc Magn Reson. 2006;8(6):789-91.

Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.

Author information

1
Cardiovascular MRI Research Centre, The Prince Charles Hospital, Brisbane, Australia.

Abstract

Cardiotoxicity is a well-known consequence of anthracycline chemotherapy. We report CMR findings not previously described in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma. Subendocardial enhancement on late gadolinium contrast-enhanced CMR was present in both cases, with histological correlation in one case.

PMID:
17060100
DOI:
10.1080/10976640600737664
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center